Bruker Announces Date and Time of Fourth Quarter 2024 Earnings Release and Webcast
Bruker (BRKR) has announced its upcoming fourth quarter and fiscal year 2024 financial results release, scheduled for Thursday, February 13, 2025, before market opening. The company will host a conference call and webcast at 8:30 a.m. Eastern Standard Time to discuss results and current business trends.
Investors can access the webcast through Bruker's investor relations website and view an accompanying slide presentation. For telephone access, participants can dial 1-888-437-2685 (U.S. toll-free) or +1-412-317-6702 (international). Pre-registration is available to expedite call entry. A replay will be accessible until March 13, 2025, via 1-877-344-7529 (U.S. toll-free) or +1-412-317-0088 (international) using code 5344184.
Bruker (BRKR) ha annunciato la pubblicazione dei risultati finanziari del quarto trimestre e dell'anno fiscale 2024, prevista per giovedì 13 febbraio 2025, prima dell'apertura del mercato. L'azienda condurrà una conferenza telefonica e una diretta web alle 8:30 a.m. ora standard orientale per discutere i risultati e le attuali tendenze aziendali.
Gli investitori possono accedere alla diretta web tramite il sito delle relazioni con gli investitori di Bruker e visualizzare una presentazione accompagnatoria. Per partecipare telefonicamente, gli utenti possono comporre il numero 1-888-437-2685 (numero verde USA) oppure +1-412-317-6702 (internazionale). È disponibile la pre-registrazione per facilitare l'ingresso alla chiamata. Una registrazione sarà accessibile fino al 13 marzo 2025, componendo il numero 1-877-344-7529 (numero verde USA) oppure +1-412-317-0088 (internazionale) utilizzando il codice 5344184.
Bruker (BRKR) ha anunciado la próxima publicación de sus resultados financieros del cuarto trimestre y del año fiscal 2024, programada para el jueves 13 de febrero de 2025, antes de la apertura del mercado. La empresa llevará a cabo una llamada de conferencia y una transmisión en vivo a las 8:30 a.m. hora estándar del este para discutir los resultados y las tendencias comerciales actuales.
Los inversores pueden acceder a la transmisión a través del sitio web de relaciones con inversores de Bruker y ver una presentación de diapositivas complementaria. Para acceder por teléfono, los participantes pueden marcar el 1-888-437-2685 (número gratuito en EE. UU.) o +1-412-317-6702 (internacional). La preinscripción está disponible para agilizar la entrada a la llamada. Una repetición estará disponible hasta el 13 de marzo de 2025, a través del 1-877-344-7529 (número gratuito en EE. UU.) o +1-412-317-0088 (internacional) usando el código 5344184.
Bruker (BRKR)는 2024 회계연도 4분기 재무결과 발표를 예고했으며, 이는 2025년 2월 13일 목요일 시장 개장 전으로 예정되어 있습니다. 이 회사는 동부 표준시 기준 오전 8시 30분에 결과와 현재 비즈니스 트렌드에 대해 논의하기 위해 전화 회의 및 웹캐스트를 진행할 것입니다.
투자자들은 Bruker의 투자자 관계 웹사이트를 통해 웹캐스트에 접속하고, 관련 슬라이드 프레젠테이션을 볼 수 있습니다. 전화로 참여하려면 1-888-437-2685 (미국 무료) 또는 +1-412-317-6702 (국제)로 전화하면 됩니다. 빠른 통화 접속을 위해 사전 등록이 가능합니다. 2025년 3월 13일까지 재생이 가능하며, 1-877-344-7529 (미국 무료) 또는 +1-412-317-0088 (국제)로 전화하여 코드 5344184를 사용하면 됩니다.
Bruker (BRKR) a annoncé la prochaine publication de ses résultats financiers du quatrième trimestre et de l'exercice 2024, prévue pour le jeudi 13 février 2025, avant l'ouverture du marché. L'entreprise organisera une conférence téléphonique et un webinaire à 8h30, heure normale de l'Est, pour discuter des résultats et des tendances commerciales actuelles.
Les investisseurs peuvent accéder au webinaire via le site web des relations investisseurs de Bruker et consulter une présentation accompagnante. Pour l’accès téléphonique, les participants peuvent composer le 1-888-437-2685 (numéro gratuit aux États-Unis) ou le +1-412-317-6702 (international). Une pré-inscription est disponible pour faciliter l'entrée à l'appel. Un enregistrement sera accessible jusqu'au 13 mars 2025, via le 1-877-344-7529 (numéro gratuit aux États-Unis) ou le +1-412-317-0088 (international) en utilisant le code 5344184.
Bruker (BRKR) hat die bevorstehende Veröffentlichung seiner finanziellen Ergebnisse für das vierte Quartal und das Geschäftsjahr 2024 angekündigt, die für Donnerstag, den 13. Februar 2025, vor Markteröffnung geplant ist. Das Unternehmen wird um 8:30 Uhr Eastern Standard Time eine Telefonkonferenz und einen Webcast abhalten, um die Ergebnisse und aktuellen Geschäftstrends zu diskutieren.
Investoren können über die Investor-Relations-Website von Bruker auf den Webcast zugreifen und eine begleitende Präsentation ansehen. Für den telefonischen Zugang können die Teilnehmer 1-888-437-2685 (US-Gebührenfrei) oder +1-412-317-6702 (international) anrufen. Eine Voranmeldung ist verfügbar, um den Eintritt in die Sitzung zu beschleunigen. Eine Aufzeichnung wird bis zum 13. März 2025 unter 1-877-344-7529 (US-Gebührenfrei) oder +1-412-317-0088 (international) mit dem Code 5344184 verfügbar sein.
- None.
- None.
To listen to the webcast, investors can go to https://ir.bruker.com and click on the “Q4 2024 Earnings Webcast” hyperlink in the “Events & Presentations” section. A slide presentation will be referenced during the webcast and will be posted to the Company’s website shortly before the webcast begins.
Investors can also listen to the earnings webcast via telephone by dialing 1-888-437-2685 (
Bruker is enabling investors to pre-register for the earnings conference call so that they can expedite their entry into the call and avoid the need to wait for a live operator. In order to pre-register for the call, investors can visit https://dpregister.com/sreg/10196649/fe70e3a396 and enter their contact information. Investors will then be issued a personalized phone number and PIN to dial into the live conference call. Individuals can pre-register any time prior to the start of the conference call on February 13.
A telephone replay of the conference call will be available by dialing 1-877-344-7529 (
About Bruker Corporation – Leader of the Post-Genomic Era (Nasdaq: BRKR)
Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit www.bruker.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250207396426/en/
Joe Kostka
Director, Investor Relations
Bruker Corporation
T: +1 (978) 313-5800
E: Investor.Relations@bruker.com
Source: Bruker Corporation
FAQ
When will Bruker (BRKR) release its Q4 2024 earnings?
What time is Bruker's (BRKR) Q4 2024 earnings call?
How can investors access Bruker's (BRKR) Q4 2024 earnings call?
Until when will Bruker's (BRKR) Q4 2024 earnings call replay be available?
